We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$10.5B
AUM Growth
+$2.57B
Cap. Flow
+$2.52B
Cap. Flow %
23.97%
Top 10 Hldgs %
3.28%
Holding
3,782
New
851
Increased
1,449
Reduced
1,127
Closed
344

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$38.7M
2
AMZN icon
Amazon
AMZN
+$33.2M
3
IP icon
International Paper
IP
+$32.8M
4
XYZ
Block Inc
XYZ
+$32.6M
5
COF icon
Capital One
COF
+$30.7M

Top Sells

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$28M
2
DKS icon
Dick's Sporting Goods
DKS
+$27.9M
3
LLY icon
Eli Lilly
LLY
+$24.9M
4
MTN icon
Vail Resorts
MTN
+$24.7M
5
ACN icon
Accenture
ACN
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Financials 13.65%
3 Industrials 12.55%
4 Consumer Discretionary 12.48%
5 Healthcare 12.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTNB icon
3376
Matinas BioPharma
MTNB
$1.81M
$20K ﹤0.01%
396
+144
+57% +$7.7K
RLMD icon
3377
Relmada Therapeutics
RLMD
$527M
$20K ﹤0.01%
909
-13,151
-94% -$292K
PTGX icon
3378
Protagonist Therapeutics
PTGX
$9.44B
$19K ﹤0.01%
546
-571
-51% -$18K
CSLT
3379
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$19K ﹤0.01%
12,024
-4,721
-28% -$7.79K
APG icon
3380
APi Group
APG
$18B
$18K ﹤0.01%
1,026
-28,064
-96% -$431K
HEPA
3381
DELISTED
Hepion Pharmaceuticals
HEPA
$18K ﹤0.01%
+16
New +$21.9K
RPAY icon
3382
Repay Holdings
RPAY
$327M
$18K ﹤0.01%
+983
New +$19.3K
NBSE
3383
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$18K ﹤0.01%
316
+90
+40% +$6.04K
BOXL icon
3384
Boxlight
BOXL
$2.13M
$17K ﹤0.01%
9
-18
-67% -$47.4K
CRBU icon
3385
Caribou Biosciences
CRBU
$164M
$17K ﹤0.01%
1,100
-9,297
-89% -$181K
WTER
3386
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$17K ﹤0.01%
+973
New +$21.2K
AZRE
3387
DELISTED
Azure Power Global Limited
AZRE
$17K ﹤0.01%
931
-1,524
-62% -$32.2K
IZEA icon
3388
IZEA Worldwide
IZEA
$61.3M
$16K ﹤0.01%
+2,902
New +$21K
AIP icon
3389
Arteris
AIP
$1.38B
$15K ﹤0.01%
+700
New +$15.9K
ASND icon
3390
Ascendis Pharma A/S
ASND
$16.8B
$15K ﹤0.01%
110
-28
-20% -$4.17K
CNMD icon
3391
CONMED
CNMD
$1.47B
$15K ﹤0.01%
107
+24
+29% +$3.4K
KROS icon
3392
Keros Therapeutics
KROS
$221M
$13K ﹤0.01%
214
-4,758
-96% -$237K
LODE icon
3393
Comstock
LODE
$245M
$13K ﹤0.01%
+1,024
New +$20.1K
TOON icon
3394
Kartoon Studios
TOON
$34.9M
$13K ﹤0.01%
+1,227
New +$16K
CMRX
3395
DELISTED
Chimerix, Inc.
CMRX
$12K ﹤0.01%
1,800
-48,520
-96% -$291K
AGCB
3396
DELISTED
Altimeter Growth Corp 2
AGCB
$12K ﹤0.01%
+1,200
New +$12K
JG
3397
Aurora Mobile
JG
$29.8M
$11K ﹤0.01%
536
-55
-9% -$1.52K
TLMD
3398
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$10K ﹤0.01%
+8,100
New +$16.2K
ORIO
3399
Orion Digital Corp
ORIO
$15.3M
$8K ﹤0.01%
+806
New +$11.6K
APTX
3400
DELISTED
Aptinyx Inc. Common Stock
APTX
$8K ﹤0.01%
+2,923
New +$7.03K
134 135
136
137 138

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q4 2021 Portfolio in Review

As of Q4 2021, Cubist Systematic Strategies held 3,782 positions worth $10.5B, up 32% from $7.94B the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

Cubist Systematic Strategies deployed $2.52B of net new capital in Q4 2021, opening 851 new positions and adding to 1,449 existing holdings. Its largest new stake was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Estee Lauder, an estimated $28M trimmed.

  • Cubist Systematic Strategies's largest Q4 2021 buy was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.
  • Cubist Systematic Strategies added most to Medtronic in Q4 2021, an estimated $38.7M increase.
  • Cubist Systematic Strategies's biggest Q4 2021 reduction was Estee Lauder, cutting an estimated $28M.
  • Cubist Systematic Strategies fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $5.95M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.3% of its $10.5B portfolio in Q4 2021.
  • Cubist Systematic Strategies opened 851 new positions and closed 344 in Q4 2021.
  • Cubist Systematic Strategies's portfolio value rose 32% quarter-over-quarter to $10.5B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.